Umeclidinium bromide/vilanterol combination in the treatment of chronic obstructive pulmonary disease: a review
Dionisios Spyratos, Lazaros Sichletidis Pulmonary Department, “G Papanikolaou” Hospital, Aristotle University of Thessaloniki, Exohi, Thessaloniki, Greece Abstract: Chronic obstructive pulmonary disease (COPD) is a common disease among the elderly that could be...
Saved in:
Main Authors: | Spyratos D (Author), Sichletidis L (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New developments in the combination treatment of COPD: focus on umeclidinium/vilanterol
by: Cazzola M, et al.
Published: (2013) -
In Vitro Analysis of Aerodynamic Properties and Co-Deposition of a Fixed-Dose Combination of Fluticasone Furoate, Umeclidinium Bromide, and Vilanterol Trifenatate
by: Kittipong Maneechotesuwan, et al.
Published: (2024) -
COST-MINIMIZATION OF VILANTEROL / UMECLIDINIUM VERSUS OLODATEROL / TIOTROPIUM IN THE BASIC THERAPY OF SEVERE AND VERY SEVERE COPD
by: E. G. Kosolapov, et al.
Published: (2017) -
Budget Impact Analysis of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Asthma in the Dubai Academic Healthcare Corporation
by: Hamouda M, et al.
Published: (2023) -
Clinical potential of aclidinium bromide in chronic obstructive pulmonary disease
by: Zhong J, et al.
Published: (2014)